Search

everythinglearnresearchcommunity

for

Search:↓

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

Menopause affects hair and skin; more research needed for treatment.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Follicular unit hair transplantation is the standard method for natural-looking hair restoration in androgenic alopecia.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Early treatment helps stop hair loss in women of color.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

Topical finasteride helps regrow hair and reduce hair loss in men and women.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

PRP and cell therapies may help with hair loss, but more research is needed.

Coenzyme Q10 vesicular formulations can potentially treat androgenic alopecia by promoting hair growth and thickness.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.